Insight into the Allosteric Inhibition of Abl Kinase

2014 ◽  
Vol 54 (5) ◽  
pp. 1325-1338 ◽  
Author(s):  
Anna Lucia Fallacara ◽  
Cristina Tintori ◽  
Marco Radi ◽  
Silvia Schenone ◽  
Maurizio Botta
2013 ◽  
Vol 81 (4-5) ◽  
pp. 431-446 ◽  
Author(s):  
Sarah C. Atkinson ◽  
Con Dogovski ◽  
Matthew T. Downton ◽  
Peter E. Czabotar ◽  
Renwick C. J. Dobson ◽  
...  

2008 ◽  
Vol 19 (1) ◽  
pp. 378-393 ◽  
Author(s):  
Traci L. Stevens ◽  
Edward M. Rogers ◽  
Laura M. Koontz ◽  
Donald T. Fox ◽  
Catarina C.F. Homem ◽  
...  

Signaling by the nonreceptor tyrosine kinase Abelson (Abl) plays key roles in normal development, whereas its inappropriate activation helps trigger the development of several forms of leukemia. Abl is best known for its roles in axon guidance, but Abl and its relatives also help regulate embryonic morphogenesis in epithelial tissues. Here, we explore the role of regulation of Abl kinase activity during development. We first compare the subcellular localization of Abl protein and of active Abl, by using a phosphospecific antibody, providing a catalog of places where Abl is activated. Next, we explore the consequences for morphogenesis of overexpressing wild-type Abl or expressing the activated form found in leukemia, Bcr-Abl. We find dose-dependent effects of elevating Abl activity on morphogenetic movements such as head involution and dorsal closure, on cell shape changes, on cell protrusive behavior, and on the organization of the actin cytoskeleton. Most of the effects of Abl activation parallel those caused by reduction in function of its target Enabled. Abl activation leads to changes in Enabled phosphorylation and localization, suggesting a mechanism of action. These data provide new insight into how regulated Abl activity helps direct normal development and into possible biological functions of Bcr-Abl.


BMC Cancer ◽  
2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Afsar Ali Mian ◽  
Anna Metodieva ◽  
Susanne Badura ◽  
Mamduh Khateb ◽  
Nili Ruimi ◽  
...  

Blood ◽  
2006 ◽  
Vol 107 (12) ◽  
pp. 4888-4897 ◽  
Author(s):  
Valerie L. Goss ◽  
Kimberly A. Lee ◽  
Albrecht Moritz ◽  
Julie Nardone ◽  
Erik J. Spek ◽  
...  

Abstract The Bcr-Abl fusion kinase drives oncogenesis in chronic myeloid leukemia (CML). CML patients are currently treated with the Abl tyrosine kinase inhibitor imatinib, which is effective in early stages of the disease. However, resistance to imatinib arises in later disease stages primarily because of a Bcr-Abl mutation. To gain deeper insight into Bcr-Abl signaling pathways, we generated phosphotyrosine profiles for 6 cell lines that represent 3 Bcr-Abl fusion types by using immunoaffinity purification of tyrosine phosphopeptides followed by tandem mass spectrometry. We identified 188 nonredundant tyrosine-phosphorylated sites, 77 of which are novel. By comparing the profiles, we found a number of phosphotyrosine sites common to the 6 cell lines regardless of cellular background and fusion type, several of which are decreased by imatinib treatment. Comparison of this Bcr-Abl signature with the profile of cells expressing an alternative imatinib-sensitive fusion kinase, FIP1L1-PDGFRα, revealed that these kinases signal through different pathways. This phosphoproteomic study of the Bcr-Abl fusion kinase highlights novel disease markers and potential drug-responsive biomarkers and adds novel insight into the oncogenic signals driven by the Bcr-Abl kinase.


2016 ◽  
pp. 381-403
Author(s):  
Anna Lucia Fallacara ◽  
Silvia Schenone ◽  
Maurizio Botta

2021 ◽  
Vol 28 (7) ◽  
pp. 614-625
Author(s):  
Man Pan ◽  
Yuanyuan Yu ◽  
Huasong Ai ◽  
Qingyun Zheng ◽  
Yuan Xie ◽  
...  

2017 ◽  
Vol 31 (S1) ◽  
Author(s):  
Karolina Michalska ◽  
Samantha Wellington ◽  
Partha P. Nag ◽  
Robert Jedrzejczak ◽  
Natalia I. Maltseva ◽  
...  

2017 ◽  
Vol 73 (a1) ◽  
pp. a428-a428
Author(s):  
Andrzej Joachimiak ◽  
Samantha Wellington ◽  
Partha P. Nag ◽  
Robert Jedrzejczak ◽  
Natalia I. Maltseva ◽  
...  

2016 ◽  
Vol 291 (16) ◽  
pp. 8836-8847 ◽  
Author(s):  
John Wojcik ◽  
Allan Joaquim Lamontanara ◽  
Grzegorz Grabe ◽  
Akiko Koide ◽  
Louesa Akin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document